T1	Entity 21 26	MTHFR
T2	SNP 0 13	Polymorphisms
T3	Association 36 46	associated
E1	Association:T3 bc:T4 snp_int:T2
T4	Cancer 52 65	breast cancer
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T5	Other_effect 75 84	prognosis
E2	Other_effect:T5 Agent:T2 Theme:T4
T6	Entity 90 108	Chinese population
R2	Population_assignment Arg1:T2 Arg2:T6	
T7	Entity 306 341	Methylenetetrahydrofolate reductase
R3	Equiv Arg1:T1 Arg2:T7	
T8	Spec 441 448	examine
T9	SNP 457 488	single nucleotide polymorphisms
T10	SNP 490 493	SNP
R4	Equiv Arg1:T10 Arg2:T9	
T11	Entity 502 507	MTHFR
T12	Association 517 527	associated
E3	Association:T12 bc:T13 snp_int:T10
R5	Speculation_marker Arg1:E3 Arg2:T8	
T13	Cancer 554 567	breast cancer
R6	SNP_coupled_gene Arg1:T10 Arg2:T11	
T14	Protective_effect 542 550	survival
E4	Protective_effect:T14 Agent:T10 Theme:T13
R7	Speculation_marker Arg1:E4 Arg2:T8	
T15	Organic_inorganic_molecules_affected 585 591	levels
E5	Organic_inorganic_molecules_affected:T15 Agent:T10 Theme:T16
R8	Speculation_marker Arg1:E5 Arg2:T8	
T16	Entity 572 584	serum folate
R9	Population_assignment Arg1:T9 Arg2:T6	
T17	SNP 785 794	rs1801133
T18	SNP 626 643	nine tagging SNPs
T19	Entity 651 656	MTHFR
R10	SNP_coupled_gene Arg1:T18 Arg2:T19	
R11	Population_assignment Arg1:T18 Arg2:T6	
A1	SNP_Class T18 tSNP
T20	Entity 770 772	TT
R12	Genotype Arg1:T17 Arg2:T20	
T21	Level 799 810	significant
T22	Effect_Type 811 820	increased
T23	Association 821 825	risk
E6	Association:T23 snp_int:T17 bc:T24
A2	Effect_Type E6 Increase
A3	Level E6 High
R14	Effect_type_marker Arg1:E6 Arg2:T22	
R15	Level_marker Arg1:E6 Arg2:T21	
T24	Cancer 829 842	breast cancer
T25	Association 821 825	risk
E7	Association:T25 snp_int:T27 bc:T24
T26	Entity 932 934	CC
T27	SNP 785 794	rs1801133
R16	Genotype Arg1:T27 Arg2:T26	
T28	Entity 949 951	CC
R13	Member Arg1:T18 Arg2:T27	
R17	Member Arg1:T18 Arg2:T17	
T29	SNP 964 973	rs9651118
R18	Member Arg1:T18 Arg2:T29	
R19	Genotype Arg1:T29 Arg2:T28	
T30	Level 984 995	significant
T31	Effect_Type 996 1003	reduced
T32	Association 1004 1008	risk
E8	Association:T32 bc:T33 snp_int:T29
A4	Effect_Type E8 Decrease
A5	Level E8 High
R20	Effect_type_marker Arg1:E8 Arg2:T31	
R21	Level_marker Arg1:E8 Arg2:T30	
T33	Cancer 1012 1025	breast cancer
T34	Entity 1078 1080	TT
T35	SNP 964 973	rs9651118
R22	Genotype Arg1:T35 Arg2:T34	
R23	Member Arg1:T18 Arg2:T35	
T36	Association 1004 1008	risk
E9	Association:T36 snp_int:T35 bc:T33
T37	Entity 1127 1132	MTHFR
T38	Interaction 1133 1139;1151 1161	CACCAA haplotypes
E10	Interaction:T38 
T39	Interaction 1144 1161	AGTCAC haplotypes
E11	Interaction:T39 Entity:T40 Entity2:T41 Entity3:T42 Entity4:T43 Entity5:T44 Entity6:T45
T40	SNP 1163 1173	rs12121543
T41	SNP 1174 1184	rs13306553
T42	SNP 1185 1194	rs9651118
T43	SNP 1195 1204	rs1801133
T44	SNP 1205 1214	rs4846048
T45	SNP 1215 1224	rs1801131
R24	SNP_coupled_gene Arg1:E10 Arg2:T37	
R25	SNP_coupled_gene Arg1:E11 Arg2:T37	
R26	Population_assignment Arg1:E11 Arg2:T6	
T46	Interaction 1365 1381	CATTAA haplotype
E12	Interaction:T46 
T47	Level 1230 1241	significant
T48	Effect_Type 1242 1249	reduced
T49	Association 1250 1254	risk
E13	Association:T49 bc:T50 snp_int:E11 snp_int2:E10
A6	Effect_Type E13 Decrease
A7	Level E13 High
R27	Effect_type_marker Arg1:E13 Arg2:T48	
R28	Level_marker Arg1:E13 Arg2:T47	
T50	Cancer 1258 1271	breast cancer
E14	Association:T49 bc:T50 snp_int:E12
T51	Entity 1392 1397	MTHFR
T52	SNP 1398 1407	rs9651118
T53	Entity 1408 1410	CC
R29	Genotype Arg1:T52 Arg2:T53	
R30	SNP_coupled_gene Arg1:T52 Arg2:T51	
T54	Level 1424 1437	significantly
T55	Protective_effect 1454 1462	survival
E15	Protective_effect:T55 Theme:T56 Agent:T52
R31	Level_marker Arg1:E15 Arg2:T54	
A8	Level E15 High
T56	Cancer 1466 1479	breast cancer
R32	Population_assignment Arg1:T52 Arg2:T6	
T57	Neg 1546 1550	none
T58	SNP 1558 1562	SNPs
T59	Entity 1570 1575	MTHFR
R33	SNP_coupled_gene Arg1:T58 Arg2:T59	
T60	Organic_inorganic_molecules_affected 1585 1595;1614 1619	associated level
E16	Organic_inorganic_molecules_affected:T60 Agent:T58 Theme:T61
R34	Negation_marker Arg1:E16 Arg2:T57	
R35	Equiv Arg1:T18 Arg2:T58	
T61	Entity 1601 1613	serum folate
T62	SNP 1669 1677	variants
T63	Spec 1696 1709	may influence
T64	Entity 1685 1690	MTHFR
R36	SNP_coupled_gene Arg1:T62 Arg2:T64	
T65	Association 1714 1718	risk
E17	Association:T65 bc:T66
T66	Cancer 1736 1749	breast cancer
T67	Other_effect 1723 1732	prognosis
E18	Other_effect:T67 Agent:T62 Theme:T66
R37	Speculation_marker Arg1:E17 Arg2:T63	
R38	Speculation_marker Arg1:E18 Arg2:T63	
R39	SNP_coupled_gene Arg1:E12 Arg2:T37	
R40	Population_assignment Arg1:E12 Arg2:T6	
